Frankfurt am Main, Germany

Jochen Goerlitzer

USPTO Granted Patents = 23 

 

Average Co-Inventor Count = 6.6

ph-index = 4

Forward Citations = 40(Granted Patents)


Company Filing History:


Years Active: 2006-2017

Loading Chart...
Loading Chart...
23 patents (USPTO):

Title: Innovations and Contributions of Jochen Goerlitzer

Introduction

Jochen Goerlitzer is a prominent inventor based in Frankfurt am Main, Germany. With an impressive portfolio of 23 patents, he has made significant contributions to the fields of pharmacology and medicinal chemistry.

Latest Patents

Among his latest innovations, Jochen developed thienomethylpiperazine derivatives as inhibitors of soluble epoxide hydrolase. This invention relates to compounds of a specific formula that demonstrate pharmacologically active properties, particularly in the therapy and prevention of various medical conditions, including renal failure, diabetic nephropathy, and cardiovascular diseases. Furthermore, it encompasses the processes for preparing these compounds and their integration as active ingredients in pharmaceuticals.

Additionally, Jochen has worked on substituted isoquinoline and isoquinolinone derivatives, which are designed to treat diseases associated with Rho-kinase and related phosphorylation processes. These compounds hold potential for therapeutic applications and are included in compositions aimed at medical use.

Career Highlights

Jochen's professional journey includes significant roles at well-regarded pharmaceutical companies, such as Sanofi and Sanofi-Aventis Deutschland GmbH. These experiences have enriched his expertise in drug development and innovation.

Collaborations

Throughout his career, Jochen has collaborated with notable colleagues, including Stefanie Keil and Wolfgang Wendler. These collaborations have likely contributed to the advancement of their research and the development of innovative therapeutic solutions.

Conclusion

Jochen Goerlitzer stands out as an influential figure in the field of pharmacology, supported by his extensive patent portfolio and collaborative efforts. His work continues to shape the future of medical treatments and provides hope for various health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…